Market Indices
Latest News
| ||
| ||
|
Price Targets
Wei Xiong from UBS issued a price target of $13.00 for TME on 2026-03-18 15:52:00.The adjusted price target was set to $13.00.At the time of the announcement, TME...
March 18, 2026 TME -1.02%
Ellie Jiang from Macquarie issued a price target of $10.70 for TME on 2026-03-17 18:46:00.The adjusted price target was set to $10.70.At the time of the announcement, TME...
March 17, 2026 TME -1.02%
Greg Renza from Truist Financial issued a price target of $8.00 for BCYC on 2026-03-17 15:51:00.The adjusted price target was set to $8.00.At the time of the announcement,
March 17, 2026 BCYC 6.47%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| ADAG Adagene Inc. | 4.65
18.62% | ||||||||||||||||||
| NCNA NuCana plc | 1.59
13.57% | ||||||||||||||||||
| COE 51Talk Online Education G | 21.50
12.80% | ||||||||||||||||||
| HUIZ Huize Holding Limited | 1.35
11.57% | ||||||||||||||||||
| NBTX Nanobiotix S.A. | 34.43
11.53% | ||||||||||||||||||
| FORTY Formula Systems (1985) Lt | 122.96
11.50% | ||||||||||||||||||
| CD Chaince Digital Holdings | 4.42
11.06% | ||||||||||||||||||
| TRIB Trinity Biotech plc | 0.60
10.90% | ||||||||||||||||||
Annual/Quarterly Reports Summary
Summit Therapeutics Inc. (SMMT) Quarterly Report: What Does It Reveal About Their Sector Performance
May 1, 2025 SMMT -0.05%
In a landscape of rising revenues and increasing operational costs, the company navigates challenges with a focus on innovation and sustainability. Despite a dip in net income and profit declines...
February 5, 2025 TEVA 0.65%
In a year marked by resilience, the company celebrated record revenues of $25 billion, driven by strong ticket sales and operational efficiency. With a focus on North America, it reduced...
January 27, 2025 CUK 2.72%